NCT06404450

Transforming Health and Reducing Perinatal Anxiety Through Virtual Engagement

Name: Clinical Trial NCT06404450
Creator: University of California, San Francisco
Keywords: Anxiety, Digital CBT, behavioral, clinical trial, United States of America

Transforming Health and Reducing PerInatal Anxiety Through Virtual Engagement (the HOPE THRIVE STUDY)

University of California, San Francisco·ClinicalTrials.gov·behavioralRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Anxiety
Drug/Device/Intervention: Digital CBT
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: University of California, San Francisco
Location: San Francisco, United States of America

Timeline & enrollment

Phase: N/A
Start date: May 15, 2024
End date: Dec 01, 2025
Enrollment: 132 participants

Primary outcome

Anxiety Symptoms

Summary

The goal of this clinical trial is to evaluate whether digital cognitive behavioral therapy (dCBT) can be used to address clinical anxiety in marginalized and low-income pregnant people in California. The main question it aims to answer is:  What is the efficacy of digital cognitive behavioral therapy (dCBTI) for reducing clinical anxiety among marginalized and low-income pregnant people?  Participants will receive digital cognitive behavioral therapy immediately, or 10 weeks after enrollment (i.e., waitlist control). Participants will complete surveys and interviews until 6-8 weeks postpartum.

ICD-10 classifications

Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06404450
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06404450 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Francisco and is currently Recruiting. The study focuses on Anxiety. Target enrollment is 132 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.